Michael Barbella, Managing Editor09.05.23
Kalos Medical Inc.'s DENEX hypertension treatment system has been granted Innovative Medical Device designation by South Korea’s Ministry of Food and Drug Safety (MFDS).
The designation recognizes medical devices that significantly improve safety and efficacy compared to existing products and treatments.
The DENEX system is a medical device that treats hypertension using minimally invasive renal denervation technology. Electrodes are inserted into the renal artery through a thin catheter tube to sympathetic nerve locations in the kidneys. The device then uses radiofrequency energy applied to the arterial wall to inactivate portions of the sympathetic nerves, which has been demonstrated to be effective at lowering blood pressure. Unlike laparoscopic surgery, the DENEX system procedure is short and safe, without the negative side effects associated with general anesthesia.
Similar to the U.S. Food and Drug Administration’s Breakthrough Device designation, the Innovative Medical Device designation is MFDS’s formal recognition of high-value medical devices that have the potential to provide more effective treatment of serious medical conditions than the current standard of care. The MFDS, in consultation with South Korea’s Ministry of Health and Welfare and other related ministries, selects medical devices for the designation, which grants special benefits such as priority MFDS review.
"We are delighted to have received the Innovative Medical Device designation and, with it, the recognition that the DENEX renal denervation system is an innovative, high technology solution, with improved safety and efficacy compared to existing hypertension treatments," Kalos Medical CEO Peter Chang stated.
Kalos Medical develops minimally invasive medical devices using proprietary catheter-based technology. Kalos Medical is conducting clinical trials in Korea and Europe for its DENEX system.
The designation recognizes medical devices that significantly improve safety and efficacy compared to existing products and treatments.
The DENEX system is a medical device that treats hypertension using minimally invasive renal denervation technology. Electrodes are inserted into the renal artery through a thin catheter tube to sympathetic nerve locations in the kidneys. The device then uses radiofrequency energy applied to the arterial wall to inactivate portions of the sympathetic nerves, which has been demonstrated to be effective at lowering blood pressure. Unlike laparoscopic surgery, the DENEX system procedure is short and safe, without the negative side effects associated with general anesthesia.
Similar to the U.S. Food and Drug Administration’s Breakthrough Device designation, the Innovative Medical Device designation is MFDS’s formal recognition of high-value medical devices that have the potential to provide more effective treatment of serious medical conditions than the current standard of care. The MFDS, in consultation with South Korea’s Ministry of Health and Welfare and other related ministries, selects medical devices for the designation, which grants special benefits such as priority MFDS review.
"We are delighted to have received the Innovative Medical Device designation and, with it, the recognition that the DENEX renal denervation system is an innovative, high technology solution, with improved safety and efficacy compared to existing hypertension treatments," Kalos Medical CEO Peter Chang stated.
Kalos Medical develops minimally invasive medical devices using proprietary catheter-based technology. Kalos Medical is conducting clinical trials in Korea and Europe for its DENEX system.